When beginning pharmacotherapy for depression
When beginning
pharmacotherapy for depression, the AGACNP discusses with the patient that a primary safety consideration includes the:
A.
Increased risk of suicide when patients begin antidepressant therapy
B.
Potential for sexual adverse effects
C.
Better likelihood of success when medications and therapy are used together
D.
High incidence of serotonin syndrome
Looking for a Similar Assignment? Order now and Get 10% Discount! Use Coupon Code "Newclient"
